Predictors for Device-Detected Subclinical Atrial Fibrillation: An Up-to-Date Narrative Review
Authors:
- Traian ChiuariuTCTraian Chiuariu
- Larisa AnghelLarisa Anghel
- Delia Melania PopaDPDelia Melania Popa
- Gavril-Silviu BîrgoanGBGavril-Silviu Bîrgoan
- Șerban Daniel FechetȘFȘerban Daniel Fechet
- Răzvan-Liviu ZanfirescuRZRăzvan-Liviu Zanfirescu
- Mircea Ovanez BalasanianMBMircea Ovanez Balasanian
- Radu Andy SascăuRSRadu Andy Sascău
- Cristian StătescuCristian Stătescu
Open Access
- 11 January 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 578
Abstract
Background: Device-detected subclinical atrial fibrillation (SCAF) and atrial high-rate episodes (AHRE) are increasingly recognized in patients with cardiac implantable electronic devices and through long-term rhythm monitoring. Although often asymptomatic, these episodes are associated with a higher risk of clinical atrial fibrillation (AF), stroke, and heart failure. Aims: This narrative review summarizes clinical, electrocardiographic, echocardiographic, and circulating biomarkers associated with the development and progression of device-detected SCAF/AHRE. Methods: We performed a comprehensive search of PubMed, Embase, and Scopus using combinations of the terms “subclinical atrial fibrillation”, “atrial high-rate episodes”, “device-detected AF”, “predictive factors”, “P-wave morphology”, “echocardiographic parameters”, “left atrial strain”, and “biological markers”. We included English-language-only studies of patients with cardiac implantable electronic devices or long-term monitoring and reporting incident SCAF/AHRE or AF as outcomes, published in the last 10 years. Results: Older age, high body mass index, heart failure, obstructive sleep apnea, and C2HEST score are consistently associated with SCAF. On-surface electrocardiogram (ECG) and device electrograms, prolonged and dispersed P-wave indices, low atrial sensing amplitude, and specific pacing configurations, particularly right ventricular apical pacing with wide QRS, predict incident and longer-lasting AHRE. Echocardiographic markers of atrial cardiomyopathy, including increased left atrial volume and impaired atrial strain, together with indices of left ventricular diastolic dysfunction, further refine risk. Among circulating biomarkers, galectin-3 and high-sensitivity C-reactive protein show the most reproducible associations with incident AHRE. Conclusions: A multiparametric approach combining clinical profile, ECG features, advanced echocardiography, and selected biomarkers may improve identification of patients at risk for device-detected SCAF. Further prospective studies are needed to define risk thresholds that justify intensified rhythm surveillance and early initiation of anticoagulation or rhythm control strategies, especially in AHRE shorter than 24 h.Keywords
This publication has 79 references indexed in Scilit:
- Left atrial volume quantification by transthoracic echocardiography versus cardiovascular magnetic resonance: a systematic review and meta-analysisThe International Journal of Cardiovascular Imaging, 2025
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2025
- Mid‐term comparison of new‐onset AHRE between His bundle and left bundle branch area pacing in patients with AV blockJournal of Arrhythmia, 2025
- The incidence and risk factors of atrial high‐rate episodes in patients with a dual‐chamber pacemakerJournal of Arrhythmia, 2024
- Automatic 3D left atrial strain extraction framework on cardiac computed tomographyComputer Methods and Programs in Biomedicine, 2024
- Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissionsJournal of Arrhythmia, 2020
- Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: From the LOOP studyAmerican Heart Journal, 2020
- Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devicesClinical Research in Cardiology, 2018
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2016
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015